Cairn Diagnostics
Cairn Diagnostics is a specialized, innovative technology company focused on pioneering, manufacturing, validating and obtaining FDA-approvals for novel breath tests intended for routine use in diagnostic medicine. Cairn develops orally administered substrates labeled with a safe, non-radioactive stable isotope of carbon, carbon-13 (13C) to generate diagnostically accurate, safe and conveniently administered breath tests. Commercially available tests are non-invasive, non-radioactive, office based, standardized and FDA-approved. Cairn serves community-based practices and partners with university-based researchers, medical device and pharmaceutical companies.
Company details
Find locations served, office locations
- Business Type:
- Technology
- Industry Type:
- Clinical Services
- Market Focus:
- Nationally (across the country)
Patients
Get quick and safe answers. GEBT is a safe, accurate, and convenient test to help diagnose gastroparesis, a condition affecting over 6 million people in the USA.
The Gastric Emptying Breath Test (“GEBT”) is a safe, FDA-approved non-radioactive test for measuring how fast your stomach empties. It can help your doctor determine if you have a condition known as delayed emptying, or “gastroparesis”.
Prior to GEBT, an alternate method used to determine how fast your stomach empties requires that you be referred to a Nuclear Medicine Center and consume radioactive materials.
You can be administered the GEBT in your doctor’s office, in a clinic or patient service center.
GEBT was validated in FDA-approved clinical studies conducted at the Mayo Clinic. GEBT has been used extensively by major pharmaceutical companies and university-based clinical researchers. GEBT has been administered to over 4,500 patients.
Healthcare Providers
Test with confidence. The Cairn GEBT is a safe, accurate, and convenient measurement of solid phase gastric emptying.
GEBT is the only FDA-approved breath test intended to be used to measure the rate of solid phase gastric emptying and aid in the diagnosis of gastroparesis. GEBT is validated against the method of gastric scintigraphy.
GEBT is a safe, non-invasive, non-radioactive, quantitative measurement of the rate of solid phase gastric emptying. It can be safely administered repeatedly and as often as every 24 hours. GEBT is an excellent choice for patients and clinicians who wish to reduce any radiation burden when a gastric emptying evaluation is needed.
GEBT is a particularly suitable alternative to gastric scintigraphy in community-based practices. GEBT is included in Expert Consensus Statements for diagnosing gastroparesis in clinical practice.
GEBT is convenient to patients as it can be administered in physician offices, clinics, patient service centers and motility clinics because it does not require healthcare professionals administering the test to undergo special training in radiation safety or radioactive materials.
GEBT is a standardized test procedure. Test results are comparable across patient evaluations, site-to-site, nationwide and worldwide.
Pharma
Get standardized results. Use GEBT to help you expedite approvals by collecting standardized and consistent results wherever clinical trials are held.
TRUSTED. GEBT is the only FDA-approved (PMA) breath test intended to be used for measurements of the rate of solid phase gastric emptying and aid in the diagnosis of gastroparesis in human subjects. GEBT is validated against the method of gastric scintigraphy.
SAFE. GEBT is a non-radioactive, non-invasive alternative to scintigraphy. GEBT can be administered in a doctor’s office or in clinic setting because it does not require healthcare professionals administering the test to undergo special training in radiation safety or radioactive materials. GEBT can be administered repeatedly and as often as every 24 hours.
CONSISTENT. GEBT is standardized. Test results are quantitative and comparable across all clinical testing sites and across patient evaluations. Standardization and non-use of radioactive material makes GEBT particularly suitable for multi-site, national and global clinical studies.
TESTED. In addition to the stringent FDA PMA approval process, GEBT has also been used in over 40 major clinical trials and administered to over 4,500 patients. GEBT has an excellent safety profile.
Research Partners
Get consistent results. GEBT is the convenient and safe test to get standardized results across all test sites.
GEBT is the only FDA-approved breath test intended to be used for measurements of the rate of solid phase gastric emptying and aid in the diagnosis of gastroparesis. GEBT is validated against the method of gastric scintigraphy.
GEBT is a non-radioactive, non-invasive alternative to scintigraphy. It can be administered in a doctor’s office or in clinic settings because GEBT does not require healthcare professionals administering the test to undergo special training in radiation safety or radioactive materials.
GEBT is standardized. Test results are quantitative and comparable across all clinical testing sites and across patient evaluations. Standardization and non-use of radioactive material makes GEBT particularly suitable for multi-site, national and global clinical studies.
GEBT is an excellent choice for patients and clinicians who wish to reduce any radiation burden when a gastric emptying evaluation is needed, especially in populations such as women of child bearing age and in patients needing repetitive measurements of gastric emptying.